Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline crossover study for opioid-related sleep-disordered breathing in obstructive sleep apnea
ACTRN12610001074088Phase 2Recruiting
- Sponsor
- NHMRC Training Fellowship
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of minocycline and morphine in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by NHMRC Training Fellowship. Primary endpoints: Oxygen saturation nadir during sleep, Percent total sleep time with SpO2 below 90% and 1 more. Started Nov 2010; status: recruiting.
02
Drugs
minocyclinemorphine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12610001074088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001074088.